Palmitic Acid

Palmitic Acid

SCHEMBL6559646

CC(C)O.CCCCCCCCCCCCCCCC(=O)O

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.81
PPARG P37231 7/20 0.81
PPARD Q03181 7/20 0.81
PPARA Q07869 7/20 0.81
HDAC11 Q96DB2 5/20 0.81
TSHR P16473 4/20 0.81
PTPN1 P18031 3/20 0.81
FABP4 P15090 3/20 0.81
ALDH1A1 P00352 2/20 0.81
TLR2 O60603 2/20 0.81
TDP1 Q9NUW8 2/20 0.81
FFAR1 O14842 2/20 0.81
FFAR4 Q5NUL3 2/20 0.81
KMT2A Q03164 2/20 0.81
ALOX15 P16050 2/20 0.81
HSD17B10 Q99714 2/20 0.81
SLC22A6 Q4U2R8 1/20 0.81
SLC22A8 Q8TCC7 1/20 0.81
MEN1 O00255 1/20 0.81
ESR1 P03372 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stearic Acid SCHEMBL10489552 1.00 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Octanoic Acid SCHEMBL28534845 1.00 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL1682245 1.00 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Dodecanoate SCHEMBL9748587 1.00 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL6567029 1.00 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Palmitic Acid SCHEMBL25269213 1.00 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL11054069 1.00 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL15603224 1.00 GPR84 (0.81) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL1682224 0.98 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11
Decanoic Acid SCHEMBL28753435 0.98 GPR84 (0.77) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117843479-A Method for directly recycling isopropyl alcohol-water mixed solution in isopropyl palmitate esterification process 南京威尔生物科技有限公司 2024-04-09 CN claimed
CN-107028785-A Composition and its cosmetic use comprising alkoxy silane, fatty ester and organosilicon 莱雅公司 2017-08-11 CN claimed
CN-117843479-A Method for directly recycling isopropyl alcohol-water mixed solution in isopropyl palmitate esterification process 南京威尔生物科技有限公司 2024-04-09 CN disclosed
CN-113527950-B Method for improving corrosion resistance of hinge 长虹美菱股份有限公司 2022-03-22 CN disclosed
CN-113527950-A Method for improving corrosion resistance of hinge 长虹美菱股份有限公司 2021-10-22 CN disclosed
CN-112165949-A Topical therapy using taxane nanoparticles for the treatment of Cervical Intraepithelial Neoplasia (CIN) and cervical cancer DFB索里亚有限责任公司 2021-01-01 CN disclosed
CN-107072918-A Polysaccharide containing sunscreen agents with reduced propensity to stain fabrics 拜尔斯道夫股份有限公司 2017-08-18 CN disclosed
CN-107028785-A Composition and its cosmetic use comprising alkoxy silane, fatty ester and organosilicon 莱雅公司 2017-08-11 CN disclosed
CN-103338745-B Skin external preparation and production method thereof SHOWA DENKO KABUSHIKI KAISHA (JP) 2016-06-01 CN disclosed
CN-105434261-A Mosquito repellent toilet water QINGDAO KELIKE INFORMATION TECH CO LTD 2016-03-30 CN disclosed
CN-104042542-A Mosquito repellent and skin care floral water QINGDAO BOHONG MARINE BIOTECHNOLOGY CO LTD 2014-09-17 CN disclosed
CN-101509189-B Crude oil type treating agent for synthetic fiber filament yarn and treating method thereof TAKEMOTO OIL & FAT SUZHOU CO LTD 2013-02-27 CN disclosed
CN-101331275-B Tissue product having a transferable additive composition KIMBERLY CLARK CO 2012-11-21 CN disclosed
CN-102451147-A Floral water with skin caring effect XUEJUN LI 2012-05-16 CN disclosed
CN-101662938-A Inactivation of mineral-coated nanobacteria STERIS INC 2010-03-03 CN disclosed
CN-101509189-A Crude oil type treating agent for synthetic fiber filament yarn and treating method thereof TAKEMOTO OIL AND FAT SUZHOU CO (CN) 2009-08-19 CN disclosed
CN-101331275-A Tissue product having a transferable additive composition DOW GLOBAL TECHNOLOGIES INC (US) 2008-12-24 CN disclosed
EP-1397108-A1 MICROEMULSION FACIAL WASHES COMPRISING SPECIFIC OILS Unilever Plc (GB) 2004-03-17 EP disclosed
US-20030095990-A1 Microemulsion facial washes comprising specific oils UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-05-22 US disclosed
WO-2002102327-A1 MICROEMULSION FACIAL WASHES COMPRISING SPECIFIC OILS UNILEVER PLC (GB) 2002-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030095990-A1 Microemulsion facial washes comprising specific oils MGLL, SQLE, LIPA GPR84 13/4885PPARG 204/4885PPARD 252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.